Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas Bollyky
Apr. 14, 2013
POLL: 62% Of Americans Believe Confederate Statues Should Remain, Only 27% Disagree
Trump Tells The Truth About Alt-Left Violence At EPIC Press Conference; Leaves Leftists 'Literally Shaking'
These Videos Show The Alt-Left Violence Trump Talked About During His Epic Press Conference
'Final Warning' To 'White People' Goes Viral On Twitter After Charlottesville Rally
WATCH: Brave Patriot Honors Robert E. Lee With Flag And AR-15
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.